Send to a Friend Font Size: Increase Decrease

Broadfin Capital

Broadfin Capital's Portfolio

Ticker	# of Shares	Price	Value
	5,574,366	$195.32	$1,088,785,168
	2,707,851	$195.32	$528,897,458
	2,000,000	$195.32	$390,640,000
	1,839,372	$195.32	$359,266,140
SPY	440,000	$754.24	$331,865,600
	1,236,368	$195.32	$241,487,398
IWM	800,000	$287.67	$230,136,000
	1,029,012	$195.32	$200,986,624
	1,003,099	$195.32	$195,925,297
	721,073	$195.32	$140,839,979
View Additional Portfolio Information »

Broadfin Capital

Login to help us fill in information about this entity.

Form SC 13D/A STRATA Skin Sciences, Filed by: Broadfin Capital, LLC Jun 23, 2020 05:27PM

Form SC 13D/A STRATA Skin Sciences, Filed by: Broadfin Capital, LLC Jan 23, 2020 06:01AM

Form SC 13D/A STRATA Skin Sciences, Filed by: Broadfin Capital, LLC Jan 22, 2020 05:17PM

Form SC 13D/A STRATA Skin Sciences, Filed by: Broadfin Capital, LLC Nov 18, 2019 05:01PM

STRATA Skin Sciences Announces Closing of a $17 Million Equity Financing and the Formal Appointment of New Management to Accelerate Growth and Enrich its XTRAC® Business Strategy May 29, 2018 04:47PM

Apr 2, 2018 07:07AM STRATA Skin Sciences (SSKN) Reports $17M Equity Financing led by Accelmed Growth Partners; Announces Dr. Doley Rafaeli as Interim CEO
Apr 2, 2018 07:01AM STRATA Skin Sciences Announces $17 Million Equity Financing led by Accelmed Growth Partners; Appointment of Industry Veteran as Interim CEO
Mar 15, 2016 03:23PM Form SC 13D/A STRATA Skin Sciences, Filed by: Broadfin Capital, LLC